UBS Group
OKYO

UBS Group’s OKYO Pharma OKYO Stock Holding History

UBS Group’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.2K Buy
59,760
+57,588
+2,651% +$112K ﹤0.01% 7016
2025
Q4 		$4.5K Buy
+2,172
New +$4.71K ﹤0.01% 8825
2025
Q3 		– Sell
-115
Closed -$296 – 10753
2025
Q2 		$296 Buy
+115
New +$195 ﹤0.01% 9886
2025
Q1 		– Sell
-2,998
Closed -$3.45K – 10578
2024
Q4 		$3.45K Buy
2,998
+2,473
+471% +$2.65K ﹤0.01% 8878
2024
Q3 		$536 Sell
525
-1,379
-72% -$1.59K ﹤0.01% 8906
2024
Q2 		$2.27K Buy
+1,904
New +$2.67K ﹤0.01% 8392
2023
Q4 		– Sell
-95
Closed -$176 – 9735
2023
Q3 		$176 Buy
+95
New +$160 ﹤0.01% 8743
2023
Q1 		– Sell
-7,523
Closed -$14.4K – 10145
2022
Q4 		$14.4K Buy
7,523
+6,341
+536% +$13.9K ﹤0.01% 8079
2022
Q3 		$3K Sell
1,182
-2,485
-68% -$5.98K ﹤0.01% 9565
2022
Q2 		$8K Buy
+3,667
New +$8.25K ﹤0.01% 8329

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group's OKYO Position: Q1 2026 in Review

UBS Group increased its OKYO Pharma (OKYO) stake by 2,651% in Q1 2026, buying an estimated $112K and bringing the position to 59,760 shares worth $96.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7016.

UBS Group first reported a position in OKYO in Q2 2022 and has held it in 10 quarters since. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • UBS Group held 59,760 shares of OKYO Pharma worth $96.2K as of Q1 2026.
  • UBS Group bought 57,588 OKYO Pharma shares in Q1 2026, an estimated $112K.
  • OKYO Pharma made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7016 holding.
  • UBS Group first reported a position in OKYO Pharma in Q2 2022 and has held it in 10 quarters since.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.